1. Home
  2. MBINM vs IDYA Comparison

MBINM vs IDYA Comparison

Compare MBINM & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBINM
  • IDYA
  • Stock Information
  • Founded
  • MBINM N/A
  • IDYA 2015
  • Country
  • MBINM United States
  • IDYA United States
  • Employees
  • MBINM 663
  • IDYA N/A
  • Industry
  • MBINM Major Banks
  • IDYA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MBINM Finance
  • IDYA Health Care
  • Exchange
  • MBINM Nasdaq
  • IDYA Nasdaq
  • Market Cap
  • MBINM N/A
  • IDYA 1.9B
  • IPO Year
  • MBINM N/A
  • IDYA 2019
  • Fundamental
  • Price
  • MBINM N/A
  • IDYA $22.10
  • Analyst Decision
  • MBINM
  • IDYA Strong Buy
  • Analyst Count
  • MBINM 0
  • IDYA 13
  • Target Price
  • MBINM N/A
  • IDYA $53.42
  • AVG Volume (30 Days)
  • MBINM N/A
  • IDYA 1.0M
  • Earning Date
  • MBINM N/A
  • IDYA 08-05-2025
  • Dividend Yield
  • MBINM N/A
  • IDYA N/A
  • EPS Growth
  • MBINM N/A
  • IDYA N/A
  • EPS
  • MBINM N/A
  • IDYA N/A
  • Revenue
  • MBINM N/A
  • IDYA $7,000,000.00
  • Revenue This Year
  • MBINM N/A
  • IDYA $101.20
  • Revenue Next Year
  • MBINM N/A
  • IDYA $286.70
  • P/E Ratio
  • MBINM N/A
  • IDYA N/A
  • Revenue Growth
  • MBINM N/A
  • IDYA N/A
  • 52 Week Low
  • MBINM N/A
  • IDYA $13.45
  • 52 Week High
  • MBINM N/A
  • IDYA $44.42
  • Technical
  • Relative Strength Index (RSI)
  • MBINM 39.92
  • IDYA 58.41
  • Support Level
  • MBINM $24.80
  • IDYA $20.50
  • Resistance Level
  • MBINM $25.29
  • IDYA $22.86
  • Average True Range (ATR)
  • MBINM 0.16
  • IDYA 0.95
  • MACD
  • MBINM -0.01
  • IDYA -0.13
  • Stochastic Oscillator
  • MBINM 22.50
  • IDYA 67.71

About MBINM Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: